Hospira Company Profile (NYSE:HSP)

About Hospira (NYSE:HSP)

Hospira logoHospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Generic Pharmaceuticals
  • Sub-Industry: Pharmaceuticals
  • Symbol: NYSE:HSP
  • CUSIP: 44106010
  • Web: www.hospira.com/
Average Prices:
  • 50 Day Moving Avg: $90.00
  • 200 Day Moving Avg: $88.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 24.58
  • P/E Growth: 0
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: 12.15%
  • Return on Equity: 16.51%
  • Return on Assets: 8.65%
 

Frequently Asked Questions for Hospira (NYSE:HSP)

What is Hospira's stock symbol?

Hospira trades on the New York Stock Exchange (NYSE) under the ticker symbol "HSP."

How were Hospira's earnings last quarter?

Hospira, Inc. (NYSE:HSP) released its earnings results on Wednesday, July, 29th. The company reported $0.85 earnings per share for the quarter, topping analysts' consensus estimates of $0.78 by $0.07. The firm earned $1.20 billion during the quarter, compared to the consensus estimate of $1.18 billion. Hospira had a return on equity of 16.51% and a net margin of 12.15%. The firm's revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.72 earnings per share. View Hospira's Earnings History.

Who are some of Hospira's key competitors?

How do I buy Hospira stock?

Shares of Hospira can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Hospira's stock price today?

One share of Hospira stock can currently be purchased for approximately $89.95.


MarketBeat Community Rating for Hospira (NYSE HSP)
Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  74 (Vote Outperform)
Underperform Votes:  179 (Vote Underperform)
Total Votes:  253
MarketBeat's community ratings are surveys of what our community members think about Hospira and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Hospira (NYSE:HSP) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Hospira (NYSE:HSP)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Hospira (NYSE:HSP)
Earnings by Quarter for Hospira (NYSE:HSP)
Earnings History by Quarter for Hospira (NYSE HSP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/29/2015Q215$0.78$0.85$1.18 billion$1.20 billionViewN/AView Earnings Details
4/28/2015Q115$0.51$0.97$1.08 billion$1.18 billionViewN/AView Earnings Details
2/12/2015Q414$0.41$0.53$1.12 billion$1.13 billionViewListenView Earnings Details
11/6/2014Q314$0.53$0.74$1.08 million$1.15 billionViewListenView Earnings Details
7/30/2014Q214$0.56$0.72$1.05 billion$1.14 billionViewListenView Earnings Details
4/30/2014Q114$0.49$0.60$1.02 billion$1.10 billionViewListenView Earnings Details
2/12/2014Q413$0.50$0.51$1.06 billion$1.10 billionViewListenView Earnings Details
7/31/2013Q2 2013$0.51$0.55$1.03 billion$1.03 billionViewListenView Earnings Details
5/1/2013Q1 2013$0.44$0.52$979.33 million$884.00 millionViewListenView Earnings Details
2/13/2013Q4 2012$0.54$0.55$1.04 billion$1.10 billionViewListenView Earnings Details
11/7/2012Q312$0.45$0.47$987.67 million$994.00 millionViewN/AView Earnings Details
8/1/2012$0.49$0.51ViewN/AView Earnings Details
5/1/2012$0.46$0.47ViewN/AView Earnings Details
2/14/2012$0.47$0.51ViewN/AView Earnings Details
10/26/2011$0.95$0.66ViewN/AView Earnings Details
7/27/2011$0.79$0.94ViewN/AView Earnings Details
4/26/2011$0.78$0.93ViewN/AView Earnings Details
2/2/2011$0.93$0.77ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Hospira (NYSE:HSP)
Current Year EPS Consensus Estimate: $3.16 EPS
Next Year EPS Consensus Estimate: $3.66 EPS

Dividends

Dividend History for Hospira (NYSE:HSP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Hospira (NYSE:HSP)
Insider Trades by Quarter for Hospira (NYSE:HSP)
Insider Trades by Quarter for Hospira (NYSE:HSP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/2/2015Matthew R StoberSVPSell21,833$87.49$1,910,169.17View SEC Filing  
2/27/2015Matthew R StoberSVPSell25,338$87.47$2,216,314.86View SEC Filing  
2/17/2015Thomas E WernerCFOSell1,566$87.35$136,790.10View SEC Filing  
1/15/2015Thomas E WernerCFOSell10,000$61.56$615,600.00View SEC Filing  
1/12/2015Matthew R StoberSVPSell2,000$61.80$123,600.00View SEC Filing  
12/15/2014Thomas E WernerCFOSell10,000$60.86$608,600.00View SEC Filing  
12/2/2014Richard J HoffmanCAOSell21,850$60.32$1,317,992.00View SEC Filing  
11/25/2014Marc J YoskowitzSVPSell11,523$59.93$690,573.39View SEC Filing  
11/24/2014Kenneth F MeyersSVPSell46,250$59.66$2,759,275.00View SEC Filing  
11/17/2014Thomas E WernerCFOSell10,000$57.73$577,300.00View SEC Filing  
9/15/2014Thomas E WernerCFOSell10,000$52.74$527,400.00View SEC Filing  
8/15/2014Thomas E WernerCFOSell10,000$55.13$551,300.00View SEC Filing  
7/15/2014Thomas E WernerCFOSell10,000$51.50$515,000.00View SEC Filing  
6/16/2014Thomas E WernerCFOSell10,000$50.82$508,200.00View SEC Filing  
5/21/2014Thomas WernerCFOSell30,000$47.98$1,439,400.00View SEC Filing  
5/16/2014Connie CurranDirectorSell2,000$47.44$94,880.00View SEC Filing  
5/14/2014Barbara BowlesDirectorSell2,000$47.77$95,540.00View SEC Filing  
5/13/2014Richard HoffmanCAOSell15,000$48.07$721,050.00View SEC Filing  
5/12/2014Brian SmithSVPSell40,000$48.00$1,920,000.00View SEC Filing  
3/14/2014Matthew StoberSVPSell19,217$42.28$812,494.76View SEC Filing  
2/26/2014Thomas WernerCFOSell20,000$42.53$850,600.00View SEC Filing  
9/11/2013Richard J HoffmanCAOSell9,850$39.38$387,893.00View SEC Filing  
8/16/2013Matthew StoberSVPSell4,990$40.12$200,198.80View SEC Filing  
6/7/2013Sumant RamachandraSVPSell23,702$35.69$845,924.38View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Hospira (NYSE:HSP)
Latest Headlines for Hospira (NYSE:HSP)
Source:
DateHeadline
americanbankingnews.com logoAnalyzing Depomed (DEPO) & Hospira (NYSE:HSP)
www.americanbankingnews.com - July 24 at 11:20 AM
americanbankingnews.com logoContrasting Hospira (NYSE:HSP) and Depomed (DEPO)
www.americanbankingnews.com - July 22 at 7:12 PM
americanbankingnews.com logoHospira (HSP) Receiving Favorable News Coverage, Study Finds
www.americanbankingnews.com - May 3 at 9:00 PM
americanbankingnews.com logoHospira (HSP) Earning Negative Press Coverage, Report Finds
www.americanbankingnews.com - April 30 at 7:48 AM
americanbankingnews.com logoHospira (HSP) Receives Daily Coverage Optimism Rating of 0.08
www.americanbankingnews.com - April 25 at 9:02 PM
americanbankingnews.com logoSomewhat Positive News Coverage Somewhat Likely to Affect Hospira (HSP) Stock Price
www.americanbankingnews.com - April 22 at 11:59 AM
baystreet.ca logoCanada’s Cannabis Boom Creating a $30 Billion Investment Opportunity
www.baystreet.ca - April 20 at 11:45 AM
americanbankingnews.com logoSomewhat Negative Media Coverage Extremely Likely to Affect Hospira (HSP) Stock Price
www.americanbankingnews.com - April 18 at 1:58 PM
feeds.benzinga.com logoRetrophin Appoints Ron Squarer to Board of Directors
feeds.benzinga.com - April 12 at 5:49 PM
thestreet.com logoICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit
www.thestreet.com - January 6 at 6:23 PM
bizjournals.com logoHighest paid Phoenix doctors by pharma and medical device makers
www.bizjournals.com - December 5 at 11:01 AM
seekingalpha.com logoPfizer: A Pharmaceutical Company In Transition
seekingalpha.com - November 3 at 5:23 PM
wsj.com logo[$$] ICU Medical To Buy Pfizer Unit in $1 Billion Deal
www.wsj.com - October 6 at 10:49 AM
cnbc.com logoAs opioid epidemic grows, so do prices of lifesaving overdose drugs
www.cnbc.com - September 23 at 5:09 PM
finance.yahoo.com logoPfizer Investors Mood Dampened by Second Quarter Earnings
finance.yahoo.com - August 15 at 5:44 PM
uk.finance.yahoo.com logoPfizer earnings rise, boosted by Hospira assets - Yahoo Finance UK
uk.finance.yahoo.com - May 4 at 2:11 AM
uk.finance.yahoo.com logoPfizer earnings rise, boosted by Hospira assets
uk.finance.yahoo.com - May 3 at 8:33 AM
seekingalpha.com logoPfizer: 30%+ Discount With 4% Yield - Seeking Alpha
seekingalpha.com - March 22 at 2:32 PM
seekingalpha.com logoThe Endless GAAP Vs. Non-GAAP Debate: Instead Focus On Cash Flow - Seeking Alpha
seekingalpha.com - March 17 at 10:52 AM
prnewswire.com logoHospira Announces U.S. Launch of Generic Bivalirudin for Injection
www.prnewswire.com - February 27 at 12:24 PM
prnewswire.com logoHospira and Cerner Expand Agreement to Advance Integration of I.V.-EMR Technology
www.prnewswire.com - February 25 at 11:38 PM
uk.finance.yahoo.com logoPfizer earnings fall on strong dollar, higher expenses
uk.finance.yahoo.com - February 2 at 10:50 AM
uk.finance.yahoo.com logoNovartis profits jump 73% on asset sales
uk.finance.yahoo.com - January 27 at 12:02 PM
bizjournals.com logoWhat Pfizer-Allergan means for manufacturing plant in Rocky Mount
www.bizjournals.com - November 23 at 12:55 PM
uk.finance.yahoo.com logoPfizer, Allergan weigh blockbuster merger: reports
uk.finance.yahoo.com - October 29 at 4:54 AM
moodys.com logoPfizer Inc. -- Moody's assigns A1 to Pfizer's proposed exchange notes
www.moodys.com - September 3 at 6:05 PM
bloomberg.com logoEx-Hospira CEO Trades Shares for $91 Million Cash in Pfizer Deal
www.bloomberg.com - September 3 at 4:33 PM
biz.yahoo.com logoHOSPIRA INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposit
biz.yahoo.com - September 3 at 12:38 PM
finance.yahoo.com logoTwo steady stocks among S&P 500
finance.yahoo.com - September 2 at 7:03 AM
finance.yahoo.com logoS&P 500 picks up ATVI and UAL
finance.yahoo.com - August 28 at 9:00 AM

Social

Chart

Hospira (HSP) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff